CELEX: 32021M10489
Language: en
Date: 2021-12-06 00:00:00
Title: Commission Decision of 06/12/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10489 - BAXTER / HILL-ROM) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                 Brussels, 6.12.2021
                                                                 C(2021) 9121 final
                                                                                PUBLIC VERSION
                                                                 Baxter International Inc.
                                                                 One Baxter Parkway,
                                                                 IL 60015 Deerfield
                                                                 United States
Subject:        Case M.10489 – BAXTER / HILL-ROM
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 12 November 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which Baxter
        International Inc. (‘Baxter’, US) acquires within the meaning of Article 3(1)(b) of the
        Merger Regulation control over the whole of Hill-Rom Holdings, Inc. (‘Hill-Rom’,
        US) by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             Baxter is a global heathcare company, primarily active in the development,
              manufacturing and marketing of products for treatment of chronic and acute
              medical conditions in hospitals, care centres and at home,
             Hill-Rom is a global medical equipment company that develops and markets
              products such as hospital beds and furniture, care products such as monitors,
              respiratory equipment and blood pressure instruments, as well as surgical
              products.
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 472, 23.11.2021, p. 12.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak--- 3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                  For the Commission
                                                  (Signed)
                                                  Olivier GUERSENT
                                                  Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                              2